Cathepsin G: Roles in antigen presentation and beyond

Molecular Immunology

Volumn 47, Issue 4, 2010, Pages 658-665

  Burster, Timo ^a   Macmillan, Henriette ^b   Hou, Tieying ^b   Boehm, Bernhard O ^a   Mellins, Elizabeth D ^b  

^a UNIVERSITY OF ULM   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen presenting cells; Antigen processing; Cathepsin G; MBP; MHC class II

Indexed keywords

ASPARAGINE ENDOPEPTIDASE; ASPARTIC PROTEINASE; CATHEPSIN B; CYSTEINE PROTEINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PROTEINASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL SURFACE; EMPHYSEMA; HEART INJURY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; METAPLASIA; MICROGLIA; MULTIPLE SCLEROSIS; NEUTROPHIL; NONHUMAN; PALMOPLANTAR KERATODERMA; PAPILLON LEFEVRE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SECRETORY CELL; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CATHEPSIN G; HUMANS; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; NEUTROPHILS; SUBSTRATE SPECIFICITY;

MURINAE;

EID: 72949106010     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.10.003     Document Type: Review

References (135)

1. Adkison A.M., Raptis S.Z., Kelley D.G., and Pham C.T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J. Clin. Invest. 109 (2002) 363-371
2. Allen D.H., and Tracy P.B. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J. Biol. Chem. 270 (1995) 1408-1415
3. Anderssen T., Halvorsen H., Bajaj S.P., and Osterud B. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb. Haemost. 70 (1993) 414-417
4. Baggiolini M., Bretz U., Dewald B., and Feigenson M.E. The polymorphonuclear leukocyte. Agents Actions 8 (1978) 3-10
5. Baggiolini M., Schnyder J., Bretz U., Dewald B., and Ruch W. Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. Ciba Found. Symp. (1979) 105-121
6. Baici A., Knopfel M., and Fehr K. Cathepsin G from human polymorphonuclear leukocytes cleaves human IgM. Mol. Immunol. 19 (1982) 719-727
7. Baici A., Knopfel M., and Fehr K. Cleavage of the four human IgG subclasses with cathepsin G. Scand. J. Immunol. 16 (1982) 487-498
8. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
9. Bank U., and Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69 (2001) 197-206
10. Beck H., Schwarz G., Schroter C.J., Deeg M., Baier D., Stevanovic S., Weber E., Driessen C., and Kalbacher H. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur. J. Immunol. 31 (2001) 3726-3736
11. Bennett K., Levine T., Ellis J.S., Peanasky R.J., Samloff I.M., Kay J., and Chain B.M. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22 (1992) 1519-1524
12. Boehm B.O., Rosinger S., Sauer G., Manfras B.J., Palesch D., Schiekofer S., Kalbacher H., and Burster T. Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus. Mol. Immunol. 46 (2009) 2576-2584
13. Boudier C., Godeau G., Hornebeck W., Robert L., and Bieth J.G. The elastolytic activity of cathepsin G: an ex vivo study with dermal elastin. Am. J. Respir. Cell Mol. Biol. 4 (1991) 497-503
14. Bromme D., Li Z., Barnes M., and Mehler E. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 38 (1999) 2377-2385
15. Burster T., Beck A., Poeschel S., Oren A., Baechle D., Reich M., Roetzschke O., Falk K., Boehm B.O., Youssef S., Kalbacher H., Overkleeft H., Tolosa E., and Driessen C. Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro. Immunology 121 (2007) 82-93
16. Burster T., Beck A., Tolosa E., Marin-Esteban V., Rotzschke O., Falk K., Lautwein A., Reich M., Brandenburg J., Schwarz G., Wiendl H., Melms A., Lehmann R., Stevanovic S., Kalbacher H., and Driessen C. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes. J. Immunol. 172 (2004) 5495-5503
17. Burster T., Beck A., Tolosa E., Schnorrer P., Weissert R., Reich M., Kraus M., Kalbacher H., Haring H.U., Weber E., Overkleeft H., and Driessen C. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J. Immunol. 175 (2005) 5940-5949
18. Burster T., Reich M., Zaidi N., Voelter W., Boehm B.O., and Kalbacher H. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells. Biochem. Biophys. Res. Commun. 377 (2008) 1299-1303
19. Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., Hornell T.M., and Mellins E.D. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression. Immunol. Rev. 207 (2005) 242-260
20. Castori M., Madonna S., Giannetti L., Floriddia G., Milioto M., Amato S., and Castiglia D. Novel CTSC mutations in a patient with Papillon-Lefevre syndrome with recurrent pyoderma and minimal oral and palmoplantar involvement. Br. J. Dermatol. 160 (2009) 881-883
21. Chain B.M., Free P., Medd P., Swetman C., Tabor A.B., and Terrazzini N. The expression and function of cathepsin E in dendritic cells. J. Immunol. 174 (2005) 1791-1800
22. Chapman H.A. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18 (2006) 78-84
23. Chapman H.A., Riese R.J., and Shi G.P. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59 (1997) 63-88
24. Colbert J.D., Matthews S.P., Miller G., and Watts C. Diverse regulatory roles for lysosomal proteases in the immune response. Eur. J. Immunol. (2009)
25. Cole A.M., Shi J., Ceccarelli A., Kim Y.H., Park A., and Ganz T. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97 (2001) 297-304
26. Coyle A.J., Uchida D., Ackerman S.J., Mitzner W., and Irvin C.G. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit. Care Med. 150 (1994) S63-71
27. Delamarre L., Pack M., Chang H., Mellman I., and Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307 (2005) 1630-1634
28. Delgado M.B., Clark-Lewis I., Loetscher P., Langen H., Thelen M., Baggiolini M., and Wolf M. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur. J. Immunol. 31 (2001) 699-707
29. Dewald B., Rindler-Ludwig R., Bretz U., and Baggiolini M. Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes. J. Exp. Med. 141 (1975) 709-723
30. Doring G., Frank F., Boudier C., Herbert S., Fleischer B., and Bellon G. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 154 (1995) 4842-4850
31. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H.W., Park C.G., Steinman R.M., and Nussenzweig M.C. Differential antigen processing by dendritic cell subsets in vivo. Science 315 (2007) 107-111
32. Eliassen L.T., Rekdal O., Svendsen J.S., and Osterud B. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells. Thromb. Haemost. 83 (2000) 598-604
33. Gale A.J., and Rozenshteyn D. Cathepsin G, a leukocyte protease, activates coagulation factor VIII. Thromb. Haemost. 99 (2008) 44-51
34. Garwicz D., Lennartsson A., Jacobsen S.E., Gullberg U., and Lindmark A. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 90 (2005) 38-44
35. Gonzalez-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22 (1999) 219-240
36. Gorlin R.J., Sedano H., and Anderson V.E. The syndrome of Palmar-Plantar hyperkeratosis and premature periodontal destruction of the teeth. A clinical and genetic analysis of the Papillon-Lefèvre syndrome. J. Pediatr. 65 (1964) 895-908
37. Grisolano J.L., Sclar G.M., and Ley T.J. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8989-8993
38. Hanson R.D., Connolly N.L., Burnett D., Campbell E.J., Senior R.M., and Ley T.J. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J. Biol. Chem. 265 (1990) 1524-1530
39. Hart T.C., Hart P.S., Bowden D.W., Michalec M.D., Callison S.A., Walker S.J., Zhang Y., and Firatli E. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J. Med. Genet. 36 (1999) 881-887
40. Hart T.C., and Shapira L. Papillon-Lefevre syndrome. Periodontology 2000 6 (1994) 88-100
41. Hedin S.G. Investigations on the proteolytic enzymes of the spleen of the ox. J. Physiol. 30 (1904) 155-175
42. Hedin S.G., and Rowland S. Zeit. Physiol. Chem. xxxii (1901) 341
43. Hewitt E.W., Treumann A., Morrice N., Tatnell P.J., Kay J., and Watts C. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation. J. Immunol. 159 (1997) 4693-4699
44. Hohn P.A., Popescu N.C., Hanson R.D., Salvesen G., and Ley T.J. Genomic organization and chromosomal localization of the human cathepsin G gene. J. Biol. Chem. 264 (1989) 13412-13419
45. Hu Y., and Pham C.T. Dipeptidyl peptidase I regulates the development of collagen-induced arthritis. Arthritis Rheum. 52 (2005) 2553-2558
46. Ishri R.K., Menzies S., Hersey P., and Halliday G.M. Rapid downregulation of antigen processing enzymes in ex vivo generated human monocyte derived dendritic cells occur endogenously in extended cultures. Immunol. Cell Biol. 82 (2004) 239-246
47. Kamp D.W., Dunne M., Dykewicz M.S., Sbalchiero J.S., Weitzman S.A., and Dunn M.M. Asbestos-induced injury to cultured human pulmonary epithelial-like cells: role of neutrophil elastase. J. Leukoc. Biol. 54 (1993) 73-80
48. Korkmaz B., Moreau T., and Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 90 (2008) 227-242
49. Kossel. Zeit. klin. Med. xiii (1888) 149
50. Lautwein A., Kraus M., Reich M., Burster T., Brandenburg J., Overkleeft H.S., Schwarz G., Kammer W., Weber E., Kalbacher H., Nordheim A., and Driessen C. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J. Leukoc. Biol. 75 (2004) 844-855
51. LaRosa C.A., Rohrer M.J., Benoit S.E., Rodino L.J., Barnard M.R., and Michelson A.D. Human neutrophil cathepsin G is a potent platelet activator. J. Vasc. Surg. 19 (1994) 306-318 discussion 318-319
52. Le-Barillec K., Pidard D., Balloy V., and Chignard M. Human neutrophil cathepsin G down-regulates LPS-mediated monocyte activation through CD14 proteolysis. J. Leukoc. Biol. 68 (2000) 209-215
53. Lebez D., and Kopitar M. Leucocyte proteinases. I. Low molecular weight cathepsins of F and G type. Enzymologia 39 (1970) 271-283
54. Li D.N., Matthews S.P., Antoniou A.N., Mazzeo D., and Watts C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278 (2003) 38980-38990
55. Lucey E.C., Stone P.J., Breuer R., Christensen T.G., Calore J.D., Catanese A., Franzblau C., and Snider G.L. Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes. Am. Rev. Respir. Dis. 132 (1985) 362-366
56. Mambole A., Baruch D., Nusbaum P., Bigot S., Suzuki M., Lesavre P., Fukuda M., and Halbwachs-Mecarelli L. The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J. Biol. Chem. 283 (2008) 23627-23635
57. Manoury B., Mazzeo D., Fugger L., Viner N., Ponsford M., Streeter H., Mazza G., Wraith D.C., and Watts C. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3 (2002) 169-174
58. Maynard J., Petersson K., Wilson D.H., Adams E.J., Blondelle S.E., Boulanger M.J., Wilson D.B., and Garcia K.C. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22 (2005) 81-92
59. McGettrick A.F., Barnes R.C., and Worrall D.M. SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells. The reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur. J. Biochem. 268 (2001) 5868-5875
60. McGuire M.J., Lipsky P.E., and Thiele D.L. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J. Biol. Chem. 268 (1993) 2458-2467
61. Medema J.P., Schuurhuis D.H., Rea D., van Tongeren J., de Jong J., Bres S.A., Laban S., Toes R.E., Toebes M., Schumacher T.N., Bladergroen B.A., Ossendorp F., Kummer J.A., Melief C.J., and Offringa R. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194 (2001) 657-667
62. Meier H.L., Heck L.W., Schulman E.S., and MacGlashan Jr. D.W. Purified human mast cells and basophils release human elastase and cathepsin G by an IgE-mediated mechanism. Int. Arch. Allergy Appl. Immunol. 77 (1985) 179-183
63. Metchnikoff E. Über die pathologische Bedeutung der intrazellulären. Verdauung Fortschr Med. 17 (1884) 558-569
64. Metchnikoff E. L'immunite dans les maladies infectieuses (1901), Masson, Paris 600
65. Meyer-Hoffert U. Neutrophil-derived serine proteases modulate innate immune responses. Front. Biosci. 14 (2009) 3409-3418
66. Miyata J., Tani K., Sato K., Otsuka S., Urata T., Lkhagvaa B., Furukawa C., Sano N., and Sone S. Cathepsin G: the significance in rheumatoid arthritis as a monocyte chemoattractant. Rheumatol. Int. 27 (2007) 375-382
67. 2+ rise in human platelets induced by polymorphonuclear-leucocyte-derived cathepsin G. Biochem. J. 288 Pt 3 (1992) 741-745
68. Moss C.X., Villadangos J.A., and Watts C. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Eur. J. Immunol. 35 (2005) 3442-3451
69. Mounter L.A., and Atiyeh W. Proteases of human leukocytes. Blood 15 (1960) 52-59
70. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6 (2006) 173-182
71. Nufer O., Corbett M., and Walz A. Amino-terminal processing of chemokine ENA-78 regulates biological activity. Biochemistry 38 (1999) 636-642
72. Nygaard S.D., Ganz T., and Peterson M.W. Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity. Am. J. Respir. Cell Mol. Biol. 8 (1993) 193-200
73. Ochiai T., Nakano H., Rokunohe D., Akasaka E., Toyomaki Y., Mitsuhashi Y., and Sawamura D. Novel p.M1T and recurrent p.G301S mutations in cathepsin C in a Japanese patient with Papillon-Lefevre syndrome: implications for understanding the genotype/phenotype relationship. J. Dermatol. Sci. 53 (2009) 73-75
74. Odeberg H., and Olsson I. Antibacterial activity of cationic proteins from human granulocytes. J. Clin. Invest. 56 (1975) 1118-1124
75. Ohlsson K., Olsson I., and Spitznagel K. Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe-Seylers Z. Physiol. Chem. 358 (1977) 361-366
76. Okrent D.G., Lichtenstein A.K., and Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am. Rev. Respir. Dis. 141 (1990) 179-185
77. Oleksyszyn J., and Powers J.C. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Biochemistry 30 (1991) 485-493
78. Owen C.A., and Campbell E.J. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J. Immunol. 160 (1998) 1436-1443
79. Owen C.A., and Campbell E.J. Extracellular proteolysis: new paradigms for an old paradox. J. Lab. Clin. Med. 134 (1999) 341-351
80. Owen C.A., and Campbell E.J. The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65 (1999) 137-150
81. Owen C.A., Campbell M.A., Boukedes S.S., and Campbell E.J. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G. J. Immunol. 155 (1995) 5803-5810
82. Owen C.A., Campbell M.A., Sannes P.L., Boukedes S.S., and Campbell E.J. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131 (1995) 775-789
83. Peterson M.W., Walter M.E., and Nygaard S.D. Effect of neutrophil mediators on epithelial permeability. Am. J. Respir. Cell Mol. Biol. 13 (1995) 719-727
84. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6 (2006) 541-550
85. Pham C.T. Neutrophil serine proteases fine-tune the inflammatory response. Int. J. Biochem. Cell Biol. 40 (2008) 1317-1333
86. Pham C.T., Ivanovich J.L., Raptis S.Z., Zehnbauer B., and Ley T.J. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J. Immunol. 173 (2004) 7277-7281
87. Rao N.V., Rao G.V., and Hoidal J.R. Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J. Biol. Chem 272 (1997) 10260-10275
88. Raptis S.Z., Shapiro S.D., Simmons P.M., Cheng A.M., and Pham C.T. Serine protease cathepsin G regulates adhesion-dependent neutrophil effector functions by modulating integrin clustering. Immunity 22 (2005) 679-691
89. Reeves E.P., Lu H., Jacobs H.L., Messina C.G., Bolsover S., Gabella G., Potma E.O., Warley A., Roes J., and Segal A.W. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416 (2002) 291-297
90. Rehault S., Brillard-Bourdet M., Juliano M.A., Juliano L., Gauthier F., and Moreau T. New, sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops. J. Biol. Chem. 274 (1999) 13810-13817
91. Reich M., Lesner A., Legowska A., Sienczyk M., Oleksyszyn J., Boehm B.O., and Burster T. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells. Mol. Immunol. 46 (2009) 2994-2999
92. Remold-O'Donnell E., Chin J., and Alberts M. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 5635-5639
93. Richter R., Bistrian R., Escher S., Forssmann W.G., Vakili J., Henschler R., Spodsberg N., Frimpong-Boateng A., and Forssmann U. Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. J. Immunol. 175 (2005) 1599-1608
94. Riese R.J., Wolf P.R., Bromme D., Natkin L.R., Villadangos J.A., Ploegh H.L., and Chapman H.A. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4 (1996) 357-366
95. Rindler-Ludwig R., and Braunsteiner H. Cationic proteins from human neutrophil granulocytes. Evidence for their chymotrypsin-like properties. Biochim. Biophys. Acta 379 (1975) 606-617
96. Rudensky A., and Beers C. Lysosomal cysteine proteases and antigen presentation. Ernst Schering Res Found Workshop (2006) 81-95
97. Sabri A., Alcott S.G., Elouardighi H., Pak E., Derian C., Andrade-Gordon P., Kinnally K., and Steinberg S.F. Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J. Biol. Chem. 278 (2003) 23944-23954
98. Salkowski. Zeit. klin. Med. xvii (1890) 77
99. Salvesen G., Farley D., Shuman J., Przybyla A., Reilly C., and Travis J. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26 (1987) 2289-2293
100. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., and Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275 (2000) 6819-6823
101. Scuderi P., Nez P.A., Duerr M.L., Wong B.J., and Valdez C.M. Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell. Immunol. 135 (1991) 299-313
102. Selak M.A., and Smith J.B. Cathepsin G binding to human platelets. Evidence for a specific receptor. Biochem. J. 266 (1990) 55-62
103. Senior R.M., and Campbell E.J. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells. J. Immunol. 132 (1984) 2547-2551
104. Shafer W.M., Hubalek F., Huang M., and Pohl J. Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. Infect. Immun. 64 (1996) 4842-4845
105. Shafer W.M., and Onunka V.C. Mechanism of staphylococcal resistance to non-oxidative antimicrobial action of neutrophils: importance of pH and ionic strength in determining the bactericidal action of cathepsin G. J. Gen. Microbiol. 135 (1989) 825-830
106. Shafer W.M., Onunka V.C., and Martin L.E. Antigonococcal activity of human neutrophil cathepsin G. Infect. Immun. 54 (1986) 184-188
107. Shapiro S.D., Campbell E.J., Senior R.M., and Welgus H.G. Proteinases secreted by human mononuclear phagocytes. J. Rheumatol. Suppl. 27 (1991) 95-98
108. Shi G.P., Bryant R.A., Riese R., Verhelst S., Driessen C., Li Z., Bromme D., Ploegh H.L., and Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191 (2000) 1177-1186
109. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7 (2007) 19-30
110. Starkey P.M., and Barrett A.J. Human cathepsin G. Catalytic and immunological properties. Biochem. J. 155 (1976) 273-278
111. Stoeckle C., Sommandas V., Adamopoulou E., Belisle K., Schiekofer S., Melms A., Weber E., Driessen C., Boehm B.O., Tolosa E., and Burster T. Cathepsin G is differentially expressed in primary human antigen-presenting cells. Cell. Immunol. 255 (2009) 41-45
112. Stoeckle C., and Tolosa E. Antigen processing and presentation in multiple sclerosis. Results Probl. Cell Differ. (2009) PMID: 19582405
113. Tkalcevic J., Novelli M., Phylactides M., Iredale J.P., Segal A.W., and Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12 (2000) 201-210
114. Toomes C., James J., Wood A.J., Wu C.L., McCormick D., Lench N., Hewitt C., Moynihan L., Roberts E., Woods C.G., Markham A., Wong M., Widmer R., Ghaffar K.A., Pemberton M., Hussein I.R., Temtamy S.A., Davies R., Read A.P., Sloan P., Dixon M.J., and Thakker N.S. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat. Genet. 23 (1999) 421-424
115. Turk B., Turk D., and Turk V. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477 (2000) 98-111
116. Turkington P.T. Degradation of human factor X by human polymorphonuclear leucocyte cathepsin G and elastase. Haemostasis 21 (1991) 111-116
117. Van Wetering S., Mannesse-Lazeroms S.P., Dijkman J.H., and Hiemstra P.S. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J. Leukoc. Biol. 62 (1997) 217-226
118. Villadangos J.A., and Ploegh H.L. Proteolysis in MHC class II antigen presentation: who's in charge?. Immunity 12 (2000) 233-239
119. Villadangos J.A., Riese R.J., Peters C., Chapman H.A., and Ploegh H.L. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186 (1997) 549-560
120. Villadangos J.A., and Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7 (2007) 543-555
121. Villadangos J.A., Schnorrer P., and Wilson N.S. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunol. Rev. 207 (2005) 191-205
122. Watorek W., van Halbeek H., and Travis J. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. Biol. Chem. Hoppe Seyler 374 (1993) 385-393
123. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5 (2004) 685-692
124. Watts C., Matthews S.P., Mazzeo D., Manoury B., and Moss C.X. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunol. Rev. 207 (2005) 218-228
125. Watts C., Moss C.X., Mazzeo D., West M.A., Matthews S.P., Li D.N., and Manoury B. Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann. N.Y. Acad. Sci. 987 (2003) 9-14
126. Willstätter R.A.B.E. Über die Proteasen der Magenschleimhaut. Erste Abhandlung über die Enzyme der Leukocyten. Hoppe-Seylers Z. Physiol. Chem. 180 (1929) 127-143
127. Wilson T.J., Nannuru K.C., Futakuchi M., Sadanandam A., and Singh R.K. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand. Cancer Res. 68 (2008) 5803-5811
128. Wilson T.J., Nannuru K.C., and Singh R.K. Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction. Mol. Cancer Res. 7 (2009) 1224-1233
129. Wittamer V., Bondue B., Guillabert A., Vassart G., Parmentier M., and Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175 (2005) 487-493
130. Wysocka M., Legowska A., Bulak E., Jaskiewicz A., Miecznikowska H., Lesner A., and Rolka K. New chromogenic substrates of human neutrophil cathepsin G containing non-natural aromatic amino acid residues in position P1 selected by combinatorial chemistry methods. Mol. Divers. 11 (2007) 93-99
131. Yamazaki T., and Aoki Y. Cathepsin G binds to human lymphocytes. J. Leukoc. Biol. 61 (1997) 73-79
132. Yang Y., Bai X., Liu H., Li L., Cao C., and Ge L. Novel mutations of cathepsin C gene in two Chinese patients with Papillon-Lefevre syndrome. J. Dent. Res. 86 (2007) 735-738
133. Zaidi N., Burster T., Sommandas V., Herrmann T., Boehm B.O., Driessen C., Voelter W., and Kalbacher H. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. Biochem. Biophys. Res. Commun. 364 (2007) 243-249
134. Zaidi N., and Kalbacher H. Cathepsin E: a mini review. Biochem. Biophys. Res. Commun. 367 (2008) 517-522
135. Zavasnik-Bergant T., and Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 67 (2006) 349-355